Literature DB >> 3066395

Partial deletion of chromosome 11p in breast cancer correlates with size of primary tumour and oestrogen receptor level.

J Mackay1, P A Elder, D J Porteous, C M Steel, R A Hawkins, J J Going, U Chetty.   

Abstract

In a study of DNAs from 100 breast cancer patients and 100 controls, there were no differences in the frequencies of common or rare alleles at the Harvey ras (c-Ha-ras) locus on chromosome 11. However, one Ha-ras allele was deleted from the tumour DNA in 14 of 65 informative patients. Loss of a Ha-ras allele correlates with paucity of oestrogen receptor protein and with increased tumour size at presentation, but is not associated with microscopic evidence of lymph node invasion. The findings on Ha-ras and other informative loci are consistent with the possibility that a tumour suppressor gene involved in the early stages of breast cancer is located on the short arm of chromosome 11.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3066395      PMCID: PMC2246883          DOI: 10.1038/bjc.1988.295

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  36 in total

1.  Loss of genes on chromosome 22 in tumorigenesis of human acoustic neuroma.

Authors:  B R Seizinger; R L Martuza; J F Gusella
Journal:  Nature       Date:  1986 Aug 14-20       Impact factor: 49.962

2.  Parasexual analysis of human pepsinogen molecular heterogeneity.

Authors:  R T Taggart; T K Mohandas; G I Bell
Journal:  Somat Cell Mol Genet       Date:  1987-03

3.  Abbott monoclonal enzyme immunoassay measurement of estrogen receptors in human breast cancer: a European multicenter study.

Authors:  G Leclercq; H Bojar; J Goussard; R I Nicholson; M F Pichon; A Piffanelli; A Pousette; S Thorpe; M Lonsdorfer
Journal:  Cancer Res       Date:  1986-08       Impact factor: 12.701

4.  Variable numbers of pepsinogen genes are located in the centromeric region of human chromosome 11 and determine the high-frequency electrophoretic polymorphism.

Authors:  R T Taggart; T K Mohandas; T B Shows; G I Bell
Journal:  Proc Natl Acad Sci U S A       Date:  1985-09       Impact factor: 11.205

5.  Loss of heterozygosity in human ductal breast tumors indicates a recessive mutation on chromosome 13.

Authors:  C Lundberg; L Skoog; W K Cavenee; M Nordenskjöld
Journal:  Proc Natl Acad Sci U S A       Date:  1987-04       Impact factor: 11.205

6.  Ha-ras hypervariable alleles in myelodysplasia.

Authors:  S L Thein; D G Oscier; J Flint; J S Wainscoat
Journal:  Nature       Date:  1986 May 1-7       Impact factor: 49.962

7.  Loss of a c-H-ras-1 allele and aggressive human primary breast carcinomas.

Authors:  C Theillet; R Lidereau; C Escot; P Hutzell; M Brunet; J Gest; J Schlom; R Callahan
Journal:  Cancer Res       Date:  1986-09       Impact factor: 12.701

8.  High frequency of rare alleles of the human c-Ha-ras-1 proto-oncogene in breast cancer patients.

Authors:  R Lidereau; C Escot; C Theillet; M H Champeme; M Brunet; J Gest; R Callahan
Journal:  J Natl Cancer Inst       Date:  1986-09       Impact factor: 13.506

9.  Chromosomal localization of the human oncogene ERBA2.

Authors:  J R Gosden; P G Middleton; D Rout; C De Angelis
Journal:  Cytogenet Cell Genet       Date:  1986

10.  Oestrogen receptors in primary and advanced breast cancer: an eight year review of 704 cases.

Authors:  M R Williams; J H Todd; I O Ellis; C S Dowle; J L Haybittle; C W Elston; R I Nicholson; K Griffiths; R W Blamey
Journal:  Br J Cancer       Date:  1987-01       Impact factor: 7.640

View more
  17 in total

Review 1.  Genes other than BRCA1 and BRCA2 involved in breast cancer susceptibility.

Authors:  M M de Jong; I M Nolte; G J te Meerman; W T A van der Graaf; J C Oosterwijk; J H Kleibeuker; M Schaapveld; E G E de Vries
Journal:  J Med Genet       Date:  2002-04       Impact factor: 6.318

2.  Mapping of 262 DNA markers into 24 intervals on human chromosome 11.

Authors:  A Tanigami; T Tokino; S Takiguchi; M Mori; T Glaser; J W Park; C Jones; Y Nakamura
Journal:  Am J Hum Genet       Date:  1992-01       Impact factor: 11.025

3.  Isolation and mapping of 62 new RFLP markers on human chromosome 11.

Authors:  T Tokino; E Takahashi; M Mori; A Tanigami; T Glaser; J W Park; C Jones; T Hori; Y Nakamura
Journal:  Am J Hum Genet       Date:  1991-02       Impact factor: 11.025

4.  Changes of common fragile sites on chromosomes according to the menstrual cycle.

Authors:  T Furuya; J Hagiwara; H Ochi; H Tokuhiro; R Kikawada; T Karube; S Watanabe
Journal:  Hum Genet       Date:  1991-03       Impact factor: 4.132

5.  The long and short of chromosome 11 in breast cancer.

Authors:  I F Newsham
Journal:  Am J Pathol       Date:  1998-07       Impact factor: 4.307

6.  Population genetics of the HRAS1 minisatellite locus.

Authors:  B Devlin; T Krontiris; N Risch
Journal:  Am J Hum Genet       Date:  1993-12       Impact factor: 11.025

Review 7.  Molecular genetic studies of early breast cancer evolution.

Authors:  P O'Connell; V Pekkel; S Fuqua; C K Osborne; D C Allred
Journal:  Breast Cancer Res Treat       Date:  1994       Impact factor: 4.872

Review 8.  Chromosomal abnormalities in human breast cancer.

Authors:  W M Mars; G F Saunders
Journal:  Cancer Metastasis Rev       Date:  1990-07       Impact factor: 9.264

Review 9.  Familial breast cancer and genes involved in breast carcinogenesis.

Authors:  A Lindblom
Journal:  Breast Cancer Res Treat       Date:  1995-05       Impact factor: 4.872

10.  Characterization of four in vitro established canine mammary carcinoma and one atypical benign mixed tumor cell lines.

Authors:  E Hellmén
Journal:  In Vitro Cell Dev Biol       Date:  1992-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.